Clinical Trials Directory

Trials / Completed

CompletedNCT05330039

Characterization of Intestinal Microbiota in Children With Inborn Errors of Metabolism (IEM)

Enterobacteria Strain-level Characterization in Children With Inborn Errors of Metabolism (IEM)

Status
Completed
Phase
Study type
Observational
Enrollment
22 (actual)
Sponsor
Emma Marie Caroline Slack · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Study around children with inborn errors of metabolism (IEM) and their healthy siblings. Collection of stool and urine to assess contribution of microbiota to disease severity.

Detailed description

This study aims to collect biological samples (stool and urine) from children with inborn errors of metabolism, IEM (like UCD (urea cycle disorder), PA (propionic aciduria) and MMA (methylmalonic aciduria) and their healthy siblings. The main focus of the study is to assess the contribution of the intestinal microbiota to disease severity in children that suffer from different forms of IEM and potentially find microbiota targets that could be used in the design of therapeutic/prophylactic agents.

Conditions

Timeline

Start date
2021-11-30
Primary completion
2024-02-27
Completion
2024-02-27
First posted
2022-04-15
Last updated
2024-03-01

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT05330039. Inclusion in this directory is not an endorsement.